Stammdaten
Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is based in Beijing, China.
Unternehmen & Branche
| Name | Yubo International Biotech Ltd |
|---|---|
| Ticker | YBGJ |
| CIK | 0000895464 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Instruments & Supplies |
| SIC | 3845 · Electromedical & Electrotherapeutic Apparatus |
Wertpapier & Kennzahlen
| CUSIP | 988366100 |
|---|---|
| ISIN | US9883661004 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,0 Mio. USD |
| Beta | 0,71 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 12,353 | -1,079,248 | -0.01 | 847,094 | -1,954,657 |
| 2025-09-30 | 10-Q | 0 | -310,152 | 0.00 | 953,211 | -1,662,888 |
| 2025-06-30 | 10-Q | 0 | -230,333 | 0.00 | 1,051,568 | -4,000,243 |
| 2025-03-31 | 10-Q | 0 | -435,630 | 0.00 | 1,166,453 | -3,669,453 |
| 2024-12-31 | 10-K | 3,470 | -1,775,648 | -0.02 | 1,534,831 | -3,424,465 |
| 2024-09-30 | 10-Q | 0 | -621,053 | -0.01 | 1,653,919 | -3,130,305 |
| 2024-06-30 | 10-Q | 0 | -527,510 | 0.00 | 1,728,582 | -2,523,481 |
| 2024-03-31 | 10-Q | 3,488 | -377,296 | 0.00 | 1,549,280 | -2,066,182 |
| 2023-12-31 | 10-K | 604,676 | -1,195,083 | -0.10 | 1,667,269 | -1,843,703 |
| 2023-09-30 | 10-Q | 428,510 | 6,293 | 0.00 | 1,903,892 | -1,100,857 |
| 2023-06-30 | 10-Q | 1,430 | -367,327 | 1,961,333 | -1,150,619 | |
| 2023-03-31 | 10-Q | 156,615 | -316,667 | 2,113,732 | -838,755 | |
| 2022-12-31 | 10-K | 104,283 | -1,204,994 | 2,348,551 | -565,373 | |
| 2022-09-30 | 10-Q | 14,580 | -238,096 | 3,719,661 | -658,141 | |
| 2022-06-30 | 10-Q | 7,970 | -491,559 | 4,050,625 | -1,251,632 | |
| 2022-03-31 | 10-Q | 15,213 | -578,948 | 4,465,753 | -760,123 | |
| 2021-12-31 | 10-K | 1,244,373 | -1,542,438 | 4,587,233 | -131,198 | |
| 2021-09-30 | 10-Q | 98,303 | -336,584 | 4,357,223 | 222,304 | |
| 2021-06-30 | 10-Q | -370,008 | 4,175,394 | 569,634 | ||
| 2021-03-31 | 10-Q | -438,676 | 3,907,379 | 926,520 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.